This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Drexel University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations in Early Detection of Hepatocellular Carcinoma by Mengjun Wang
Introduction
Mengjun Wang is an accomplished inventor based in Mount Pleasant, SC (US). He has made significant contributions to the field of medical diagnostics, particularly in the early detection of hepatocellular carcinoma. His innovative work aims to improve the accuracy and sensitivity of detecting this serious condition.
Latest Patents
Mengjun Wang holds a patent for the "Early detection of hepatocellular carcinoma." This patent provides methods, assays, and kits for detecting hepatocellular carcinoma. It also includes methods for stratifying subjects into higher and lower risk categories for having the disease. Furthermore, it outlines methods for treating and managing subjects suspected of having hepatocellular carcinoma. The invention addresses the critical need for a highly sensitive early predictor of the disease, especially for non-symptomatic subjects. The unique combinations of factors identified by Wang and his team offer a level of accuracy that was previously unattainable.
Career Highlights
Mengjun Wang is affiliated with Drexel University, where he continues to advance research in medical diagnostics. His work has garnered attention for its potential to significantly impact patient outcomes through early detection and intervention.
Collaborations
Mengjun Wang has collaborated with notable colleagues, including Timothy Michael Block and Anand Mehta. Their combined expertise enhances the research and development of innovative diagnostic methods.
Conclusion
Mengjun Wang's contributions to the early detection of hepatocellular carcinoma represent a significant advancement in medical technology. His innovative approaches have the potential to save lives by enabling timely diagnosis and treatment.